Transcription of Oncology Medication Clinical Coverage
{{id}} {{{paragraph}}}
Example: dental hygienist
Oncology Medication Clinical Coverage
Oncology Medication Clinical Coverage Page 1 of 5 UnitedHealthcare Commercial Medical Benefit Drug Policy Effective 03/01/2022 Proprietary Information of UnitedHealthcare. Copyright 2022 United HealthCare Services, Inc. UnitedHealthcare Commercial Medica l Benefit Drug Policy Oncology Medication Clinical Coverage Policy Number: 2022D0030Z Effective Date: March 1, 2022 Instructions for Use Table of Contents Page Coverage Rationale .. 1 Applicable Codes .. 3 3 Benefit Considerations .. 4 References .. 4 Policy History/Revision Information .. 5 Instructions for Use .. 5 Coverage Rationale See Benefit Considerations Description This policy provides parameters for Coverage of injectable Oncology medications (including, but not limited to octreotide acetate, leuprolide acetate, leucovorin and levoleucovorin), including therapeutic radiopharmaceuticals, covered under the medical benefit based upon the national Comprehensive Cancer Network (NCCN) Drugs & Biologics Compendium (NCCN Compendium ).
Coverage determinations are based on the OptumHealth Transplant Solutions ... Medicare does not have a National Coverage Determination (NCD) that specifically addresses preferred or non-preferred ... Refer to the Medicare Benefit Policy Manual, Chapter 15, §50 Drugs and Biologicals. (Accessed November 4, 2021)
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: